What are the contraindications to combined oral contraceptive pills for a healthy 19‑year‑old woman who is not pregnant, does not smoke heavily, and has no history of thromboembolic disease, hypertension, migraine with aura, liver disease, or estrogen‑sensitive cancer?

Contraindications to Combined Oral Contraceptive Pills

For a healthy 19-year-old non-smoker without pre-existing cardiovascular or metabolic disease, combined oral contraceptives (COCs) are generally safe with very few absolute contraindications. The U.S. Medical Eligibility Criteria (U.S. MEC) provides a clear framework for determining when COCs represent an unacceptable health risk 1.

Absolute Contraindications (Category 4 - Unacceptable Health Risk)

The following conditions represent absolute contraindications where COCs should not be used:

Cardiovascular & Thrombotic Conditions

• Current or history of venous thromboembolism (VTE) - including deep vein thrombosis or pulmonary embolism 1, 2
• Known thrombogenic mutations - such as Factor V Leiden, prothrombin mutation, protein C/S deficiency
• Current or history of ischemic heart disease or stroke 1, 3
• Complicated valvular heart disease - with pulmonary hypertension, atrial fibrillation, or history of bacterial endocarditis
• Peripartum cardiomyopathy with moderately or severely impaired cardiac function

Age and Smoking

• Age ≥35 years AND smoking ≥15 cigarettes per day 1, 4 - This combination creates unacceptable risk for myocardial infarction and stroke. Note that for women <35 years who smoke, COCs are Category 2 (generally can be used) 1.

Hypertension

• Systolic BP ≥160 mmHg or diastolic BP ≥100 mmHg 1
• Hypertension with vascular disease - regardless of blood pressure control

Migraine

• Migraine with aura at any age 1, 5 - significantly increases stroke risk when combined with estrogen
• Migraine without aura in women ≥35 years

Postpartum Period

• <3 weeks postpartum (all women) - due to elevated VTE risk 6
• 3-6 weeks postpartum with additional VTE risk factors 6
• <6 weeks postpartum if breastfeeding - Category 4 for first 3 weeks, Category 3 for weeks 4-6 6

Liver Disease

• Active viral hepatitis
• Severe (decompensated) cirrhosis
• Liver tumors (benign or malignant)

Cancer

• Current breast cancer or other estrogen-sensitive malignancies 1

Other Conditions

• Diabetes with vascular complications (nephropathy, retinopathy, neuropathy) or diabetes >20 years duration 1
• Major surgery with prolonged immobilization
• Systemic lupus erythematosus with positive antiphospholipid antibodies

Relative Contraindications (Category 3 - Risks Usually Outweigh Benefits)

These conditions warrant careful consideration and typically alternative methods should be offered:

• Adequately controlled hypertension (BP 140-159/90-99 mmHg) 1
• Age ≥35 years AND smoking <15 cigarettes per day 1, 4
• Multiple cardiovascular risk factors - including older age, smoking, diabetes, hypertension combined 1
• History of breast cancer with no recurrence for 5 years
• Symptomatic gallbladder disease or cholestasis
• Inflammatory bowel disease with active or extensive disease

Important Clinical Considerations

For the Healthy 19-Year-Old

Given the expanded context of a healthy 19-year-old who does not smoke heavily and has no history of thromboembolic disease, hypertension, migraine with aura, liver disease, or estrogen-sensitive cancer, there are essentially no contraindications to COC use 1, 2. Research demonstrates that medical contraindications in reproductive-aged women seeking COCs are rare, with only 2.38% having true contraindications in a large cohort study 2.

Pre-Prescription Assessment

Before prescribing COCs, obtain:

• Blood pressure measurement - essential to rule out hypertension 1
• Targeted history focusing on:
  • Personal or family history of VTE
  • Migraine characteristics (presence of aura)
  • Cardiovascular disease history
  • Smoking status and quantity
  • Liver disease symptoms
  • Current medications (drug interactions)

Common Pitfalls to Avoid

• Do not require pelvic examination - this is not necessary for COC initiation 1
• Do not require routine lipid screening in healthy young women without risk factors
• Do not withhold COCs based solely on family history of VTE unless patient has known thrombophilia
• Distinguish migraine with aura from migraine without aura - only migraine with aura is an absolute contraindication in young women 5
• Obesity alone is not a contraindication in young women, though it increases baseline VTE risk 4

Monitoring During Use

• Blood pressure check within 3 months of initiation, then annually 1
• If new cardiovascular symptoms develop (chest pain, severe headache, visual changes, leg swelling), discontinue immediately and evaluate

The evidence strongly supports that for healthy young women without the specific contraindications listed above, COCs represent a safe and effective contraceptive option with benefits that far outweigh risks 1, 2.